Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse MKT  >  Protalix BioTherapeutics Inc.    PLX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
08/25/2015 08/26/2015 08/27/2015 08/28/2015 08/31/2015 Date
1.34(c) 1.39(c) 1.4(c) 1.46(c) 1.47(c) Last
76 418 345 613 44 373 24 716 25 677 Volume
+0.75% +3.73% +0.72% +4.29% +0.68% Change
More quotes
Financials ($)
Sales 2013 15,8 M
EBIT 2013 -19,9 M
Net income 2013 -19,0 M
Debt 2013 -
Yield 2013 -
Sales 2014 35,8 M
EBIT 2014 -12,9 M
Net income 2014 -4,70 M
Debt 2014 -
Yield 2014 -
PER 2013 -
PER 2014
Capi. / Sales 2013 8,79x
Capi. / Sales 2014 3,87x
Capitalization 138 M
More Financials
Company
Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system.It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease.Its drug... 
More about the company
Surperformance© ratings of Protalix BioTherapeutics I
Trading Rating : Investor Rating :
More Ratings
Latest news on PROTALIX BIOTHERAPEUTICS I
08/11 PROTALIX BIOTHERAPEUTICS : Reports Second Quarter 2015 Financial Results
08/10 PROTALIX BIOTHERAPEUTICS : reports 2Q loss
08/10 PROTALIX BIOTHERAPEUTICS : Results of Operations and Financial Condition, Financ..
08/10 Protalix BioTherapeutics Reports Second Quarter 2015 Financial Results
08/03 Protalix BioTherapeutics Reports Positive Phase I Clinical Study Results for ..
07/28 PROTALIX BIOTHERAPEUTICS : CollPlant Names Shomrat Shurtz Senior Director of Bus..
07/28 COLLPLANT : Names Shomrat Shurtz Senior Director of Business Development
06/12 Protalix BioTherapeutics Announces AIR DNase(TM) Data Presented at the 38th E..
More news
Sector news : Biotechnology & Medical Research - NEC
08:01a INCYTE : to Present at Upcoming Investor Conferences
08/31 GENMAB A/S : Total Number of Voting Rights and Total Share Capital
08/31 MEDICINES : shares surge on upbeat cholesterol drug study
More sector news : Biotechnology & Medical Research - NEC
Comments 
Advertisement
Chart PROTALIX BIOTHERAPEUTICS I
Duration : Period :
Protalix BioTherapeutics I Technical Analysis Chart | PLX | US74365A1016 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions